These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18579343)

  • 1. Iron porphyrinate Fe(TPPS) reduces brain cell damage in rats intrastriatally lesioned by quinolinate.
    González-Cortés C; Salinas-Lara C; Gómez-López MA; Tena-Suck ML; Pérez-De La Cruz V; Rembao-Bojórquez D; Pedraza-Chaverrí J; Gómez-Ruiz C; Galván-Arzate S; Ali SF; Santamaría A
    Neurotoxicol Teratol; 2008; 30(6):510-9. PubMed ID: 18579343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III).
    Pérez-De La Cruz V; González-Cortés C; Galván-Arzate S; Medina-Campos ON; Pérez-Severiano F; Ali SF; Pedraza-Chaverrí J; Santamaría A
    Neuroscience; 2005; 135(2):463-74. PubMed ID: 16111817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease.
    Pérez-De La Cruz V; Elinos-Calderón D; Robledo-Arratia Y; Medina-Campos ON; Pedraza-Chaverrí J; Ali SF; Santamaría A
    Behav Brain Res; 2009 May; 199(2):210-7. PubMed ID: 19100293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S-allylcysteine reduces the MPTP-induced striatal cell damage via inhibition of pro-inflammatory cytokine tumor necrosis factor-α and inducible nitric oxide synthase expressions in mice.
    García E; Villeda-Hernández J; Pedraza-Chaverrí J; Maldonado PD; Santamaría A
    Phytomedicine; 2010 Dec; 18(1):65-73. PubMed ID: 20576415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selenium reduces the proapoptotic signaling associated to NF-kappaB pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum.
    Santamaría A; Vázquez-Román B; La Cruz VP; González-Cortés C; Trejo-Solís MC; Galván-Arzate S; Jara-Prado A; Guevara-Fonseca J; Ali SF
    Synapse; 2005 Dec; 58(4):258-66. PubMed ID: 16206188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic/prooxidant model of Huntington's disease in rats: protective role of apocynin.
    Maldonado PD; Molina-Jijón E; Villeda-Hernández J; Galván-Arzate S; Santamaría A; Pedraza-Chaverrí J
    J Neurosci Res; 2010 Feb; 88(3):620-9. PubMed ID: 19795371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S-Allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats.
    Pérez-Severiano F; Rodríguez-Pérez M; Pedraza-Chaverrí J; Maldonado PD; Medina-Campos ON; Ortíz-Plata A; Sánchez-García A; Villeda-Hernández J; Galván-Arzate S; Aguilera P; Santamaría A
    Neurochem Int; 2004 Dec; 45(8):1175-83. PubMed ID: 15380627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human FGF-1 gene delivery protects against quinolinate-induced striatal and hippocampal injury in neonatal rats.
    Hossain MA; Fielding KE; Trescher WH; Ho T; Wilson MA; Laterra J
    Eur J Neurosci; 1998 Aug; 10(8):2490-9. PubMed ID: 9767380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine.
    Silva-Adaya D; Pérez-De La Cruz V; Herrera-Mundo MN; Mendoza-Macedo K; Villeda-Hernández J; Binienda Z; Ali SF; Santamaría A
    J Neurochem; 2008 May; 105(3):677-89. PubMed ID: 18194214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.
    Ryu JK; Choi HB; McLarnon JG
    Neuroscience; 2006 Sep; 141(4):1835-48. PubMed ID: 16809003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease.
    Ryu JK; Kim SU; McLarnon JG
    Exp Neurol; 2004 May; 187(1):150-9. PubMed ID: 15081596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of inducible nitric oxide synthase and cyclooxygenase-2 after excitotoxic damage to the immature rat brain.
    Acarin L; Peluffo H; González B; Castellano B
    J Neurosci Res; 2002 Jun; 68(6):745-54. PubMed ID: 12111835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior characterization of a model of Huntington's disease in rats, induced by quinolinic acid].
    Francis L; Cruz R; Antúnez I; Rosillo JC
    Rev Neurol; 2000 Jun 1-15; 30(11):1016-21. PubMed ID: 10904945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoplasmic calcium mediates oxidative damage in an excitotoxic /energetic deficit synergic model in rats.
    Pérez-De La Cruz V; Konigsberg M; Pedraza-Chaverri J; Herrera-Mundo N; Díaz-Muñoz M; Morán J; Fortoul-van der Goes T; Rondán-Zárate A; Maldonado PD; Ali SF; Santamaría A
    Eur J Neurosci; 2008 Mar; 27(5):1075-85. PubMed ID: 18364032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nitric oxide in 3-nitropropionic acid-induced striatal toxicity in rats.
    Deshpande SB; Hida H; Takei-Io N; Masuda T; Baba H; Nishino H
    Brain Res; 2006 Sep; 1108(1):205-15. PubMed ID: 16857175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term lithium treatment promotes neuronal survival and proliferation in rat striatum infused with quinolinic acid, an excitotoxic model of Huntington's disease.
    Senatorov VV; Ren M; Kanai H; Wei H; Chuang DM
    Mol Psychiatry; 2004 Apr; 9(4):371-85. PubMed ID: 14702090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults.
    Hanbury R; Ling ZD; Wuu J; Kordower JH
    J Comp Neurol; 2003 Jun; 461(3):307-16. PubMed ID: 12746870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nitric oxide donor LA 419 decreases brain damage in a focal ischemia model.
    Martínez-Murillo R; Fernández AP; Serrano J; Rodrigo J; Salas E; Mourelle M; Martínez A
    Neurosci Lett; 2007 Mar; 415(2):149-53. PubMed ID: 17239538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolinate immunoreactivity in experimental rat brain tumors is present in macrophages but not in astrocytes.
    Moffett JR; Els T; Espey MG; Walter SA; Streit WJ; Namboodiri MA
    Exp Neurol; 1997 Apr; 144(2):287-301. PubMed ID: 9168830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.